PPIs Are Not Responsible for Elevating Cardiovascular Risk in Patients on Clopidogrel—A Systematic Review and Meta-Analysis

Background: Clopidogrel and proton pump inhibitors (PPIs) are metabolized by cytochrome P450 enzymes. Contradictory results have been reported on possible complications of simultaneous PPI and clopidogrel use. Our aim was to investigate the clinical relevance of this debate with a systematic review...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Physiol
Egile Nagusiak: Demcsák, Alexandra, Lantos, Tamás, Bálint, Emese Réka, Hartmann, Petra, Vincze, Áron, Bajor, Judit, Czopf, László, Alizadeh, Hussain, Gyöngyi, Zoltán, Márta, Katalin, Mikó, Alexandra, Szakács, Zsolt, Pécsi, Dániel, Hegyi, Péter, Szabó, Imre László
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2018
Gaiak:
Physiology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6252380/
https://ncbi.nlm.nih.gov/pubmed/30510515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2018.01550
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak